| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jiang Tianyi | Chief Executive Officer, Director | C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY | /s/ Brian Michael Brown, Attorney-in-Fact | 17 Oct 2025 | 0001865596 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVPT | Common Stock | Other | -$22.5M | -1.54M | -48.21% | $14.61 | 1.66M | 15 Oct 2025 | Direct | F1, F2, F3 |
| transaction | AVPT | Common Stock | Other | $22.5M | +1.54M | +11.15% | $14.61 | 15.4M | 15 Oct 2025 | Held by trusts and LLCs. | F1, F2, F4 |
| Id | Content |
|---|---|
| F1 | This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. |
| F2 | On October 15, 2025, the Reporting Person transferred 1,542,779 shares of common stock from direct ownership to River Valley Ltd, in connection with a loan repayment totalling $22,542,001. This transaction is reported as a change in the form of ownership from direct to indirect. |
| F3 | Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024 and March 18, 2025. |
| F4 | Includes (i) 4,210,836 shares held by Dr. Jiang's affiliate River Valley Ltd., (ii) 2,678,631 shares held by Red Kite LLC, each of which Dr. Jiang may be deemed to beneficially own, (iii) 837,060 shares held by Capella 2022 GRAT II, (iv) 3,338,392 shares held by the Capella 2023 GRAT, (v) 2,888,135 shares held by Capella 2024 GRAT, (vi) 1,259,578 shares held by Capella 2024 GRAT II, in case of each of (iii)-(vi), for which Dr. Jiang is the trustee and (vii) 172,000 shares held by Dr. Jiang's spouse. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose. |